Updated Phase 2 Trial Data Looks Promising for Experimental Alpha-1 Antitrypsin Deficiency Therapy
source: shutterstock.com

Updated Phase 2 Trial Data Looks Promising for Experimental Alpha-1 Antitrypsin Deficiency Therapy

According to an a press release published on Business Wire, Arrowhead Pharmaceuticals Inc. recently presented updated phase 2 data at the 2023 European Association for the Study of the Liver…

Continue Reading Updated Phase 2 Trial Data Looks Promising for Experimental Alpha-1 Antitrypsin Deficiency Therapy
A Top FDA Official Overrules Reviewers’ Rejection of Sarepta’s DMD Gene Therapy
source: shutterstock.com

A Top FDA Official Overrules Reviewers’ Rejection of Sarepta’s DMD Gene Therapy

  It looked as if the fate of Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy was pretty much sealed until an FDA official intervened. This information was provided by…

Continue Reading A Top FDA Official Overrules Reviewers’ Rejection of Sarepta’s DMD Gene Therapy
Uplifting Athletes Hosted 20th Anniversary Lift for Life with Penn State Football
https://pixabay.com/en/american-football-football-sports-1666276/

Uplifting Athletes Hosted 20th Anniversary Lift for Life with Penn State Football

Uplifting Athletes, a national nonprofit organization that harnesses the power of sport to support people impacted by rare diseases, celebrated 20 years of Lift for Life with Penn State University…

Continue Reading Uplifting Athletes Hosted 20th Anniversary Lift for Life with Penn State Football